Carmell Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Carmell Therapeutics's estimated annual revenue is currently $2.3M per year.(i)
  • Carmell Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Carmell Therapeutics has 15 Employees.(i)
  • Carmell Therapeutics grew their employee count by -29% last year.

Carmell Therapeutics's People

NameTitleEmail/Phone
1
President/CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Quality OfficerReveal Email/Phone
4
VP Clinical SciencesReveal Email/Phone
5
Research And Development EngineerReveal Email/Phone
6
Executive ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Carmell Therapeutics?

Carmell Therapeutics Corporation is a privately-owned biotechnology company focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs). These PBMs contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M1525%N/A
#2
$2.3M157%N/A
#3
$1.7M150%N/A
#4
$2.3M150%N/A
#5
$1.3M157%N/A